Sumitomo Pharma Patents – Insights & Stats (Updated 2023)

Sumitomo Pharma has a total of 103 patents globally, out of which 29 have been granted. Of these 103 patents, more than 68% patents are active. The United States of America is where Sumitomo Pharma has filed the maximum number of patents, followed by Canada and Mexico. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Sumitomo Pharma.

Sumitomo Pharma also known as Sumitomo Dainippon Pharma was founded in 2005. Sumitomo Pharma is a company that mainly sells specialty and generic drugs, with most of its sales coming from North America and Japan. Their main focus is on pharmaceutical products, especially in areas like cardiovascular/diabetes, psychiatry & neurology, and specialty fields. They also see mergers and acquisitions as a way to grow by improving their research, development, manufacturing, and marketing abilities.

Do read about some of the most popular patents of Sumitomo Pharma which have been covered by us in this article and also you can find Sumitomo Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sumitomo Pharma patent portfolio.

How many patents does Sumitomo Pharma have?

Sumitomo Pharma has a total of 103 patents globally. These patents belong to 44 unique patent families. Out of 103 patents, 71 patents are active.

How Many Patents did Sumitomo Pharma File Every Year?

Sumitomo Pharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSumitomo Pharma Applications FiledSumitomo Pharma Patents Granted
202254
2021106
2020176
2019101
2018121
201786
201613
201541
201451
20131
20122

How many Sumitomo Pharma patents are Alive/Dead?

Worldwide Patents

Sumitomo Pharma Patent Portfolio

How Many Patents did Sumitomo Pharma File in Different Countries?

Sumitomo Pharma Worldwide Patent Filing

Countries in which Sumitomo Pharma Filed Patents

CountryPatents
United States of America23
Canada22
Mexico13
Hong Kong (S.A.R.)13
Israel5
Europe (EPO)4
Singapore3
Austria2
New Zealand2
Philippines1
Spain1
Indonesia1
Italy1
Malaysia1

Where are Research Centers of Sumitomo Pharma Patents Located?

R&D Centres of Sumitomo Pharma

10 Best Sumitomo Pharma Patents

US20120058997A1 is the most popular patent in the Sumitomo Pharma portfolio. It has received 30 citations so far from companies like Lexicon Pharmaceuticals, Arisan Therapeutics, Califia Bio.

Below is the list of 10 most cited patents of Sumitomo Pharma:

Publication NumberCitation Count
US20120058997A130
US8877803B227
US7998966B227
US20110269772A119
US20080214558A111
US9732055B27
US9745278B26
US9834532B24
US9730909B24
CA2959951A14

What are Sumitomo Pharma key innovation segments?

What Technologies are Covered by Sumitomo Pharma?

The chart below distributes patents filed by Sumitomo Pharma in different countries on the basis of the technology protected in patents. It also represents the markets where Sumitomo Pharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Sumitomo Pharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Sumitomo Pharma?

Related Articles

Rapoo Patents – Insights & Stats (Updated 2024)

Rapoo has a total of 562 patents globally, out of which 507 have been granted. Of these 562 patents, more than 31% patents are active. China is where Rapoo has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, China seems to be

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.